Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertugliflozin renal oxygenation mechanistic crossover study in type 2 diabetes and healthy controls
2019-000730-19Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ertugliflozin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Change in renal oxygenation by BOLD-MRI. Started Mar 2020; status: completed.
02
Drugs
ertugliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2019-000730-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000730-19.